*Significant reduction in calcification demonstrated in animal models. Data on file Boston Scientific. No clinical data are available which evaluate the long-term impact of the BioFix™ tissue treatment in patients.
† Limited clinical data has shown a numerical decrease in frequency and severity of PVL in ACURATE neo2 as compared to ACURATE neo.
1. Möllmann H, Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes. Presented PCRLV 2018, London, September 10, 2018.
2. Möllmann H, Hengstenberg C, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI-TF registry. EuroIntervention. 2018;13:e1764-e1770.
